Search by Drug Name or NDC
NDC 62559-0890-30 Bicalutamide 50 mg/1 Details
Bicalutamide 50 mg/1
Bicalutamide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ANI Pharmaceuticals, Inc.. The primary component is BICALUTAMIDE.
MedlinePlus Drug Summary
Bicalutamide is used with another medication (gonadotropin-releasing hormone (GnRH) agonists; such as leuprolide or goserelin) to treat metastatic prostate cancer (cancer that started in the prostate and has spread to other parts of the body). Bicalutamide is in a class of medications called nonsteroidal antiandrogens. It works by blocking the effect of androgen (a male hormone), to stop the growth and spread of cancer cells.
Related Packages: 62559-0890-30Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Bicalutamide
Product Information
NDC | 62559-0890 |
---|---|
Product ID | 62559-890_7da87dc4-afb1-410b-a7c1-63983812c859 |
Associated GPIs | 21402420000320 |
GCN Sequence Number | 024153 |
GCN Sequence Number Description | bicalutamide TABLET 50 MG ORAL |
HIC3 | V1J |
HIC3 Description | ANTINEOPLASTIC - ANTIANDROGENIC AGENTS |
GCN | 00450 |
HICL Sequence Number | 010143 |
HICL Sequence Number Description | BICALUTAMIDE |
Brand/Generic | Generic |
Proprietary Name | Bicalutamide |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Bicalutamide |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 50 |
Active Ingredient Units | mg/1 |
Substance Name | BICALUTAMIDE |
Labeler Name | ANI Pharmaceuticals, Inc. |
Pharmaceutical Class | Androgen Receptor Antagonists [MoA], Androgen Receptor Inhibitor [EPC] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA020498 |
Listing Certified Through | 2024-12-31 |
Package
NDC 62559-0890-30 (62559089030)
NDC Package Code | 62559-890-30 |
---|---|
Billing NDC | 62559089030 |
Package | 30 TABLET in 1 BOTTLE (62559-890-30) |
Marketing Start Date | 2020-10-26 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 0.28904 |
Pricing Unit | EA |
Effective Date | 2024-02-21 |
NDC Description | BICALUTAMIDE 50 MG TABLET |
Pharmacy Type Indicator | C/I |
OTC | N |
Explanation Code | 1, 6 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis